965 related articles for article (PubMed ID: 28195391)
1. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
2. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.
Xu L; Zhou X; Wang W; Wang Y; Yin Y; Laan LJ; Sprengers D; Metselaar HJ; Peppelenbosch MP; Pan Q
FASEB J; 2016 Oct; 30(10):3352-3367. PubMed ID: 27328944
[TBL] [Abstract][Full Text] [Related]
3. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
4. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
5. Convergent Transcription of Interferon-stimulated Genes by TNF-α and IFN-α Augments Antiviral Activity against HCV and HEV.
Wang W; Xu L; Brandsma JH; Wang Y; Hakim MS; Zhou X; Yin Y; Fuhler GM; van der Laan LJ; van der Woude CJ; Sprengers D; Metselaar HJ; Smits R; Poot RA; Peppelenbosch MP; Pan Q
Sci Rep; 2016 May; 6():25482. PubMed ID: 27150018
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis E virus persists in the presence of a type III interferon response.
Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
[TBL] [Abstract][Full Text] [Related]
7. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response.
Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q
Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722
[TBL] [Abstract][Full Text] [Related]
8. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
Sooryanarain H; Heffron CL; Meng XJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
[TBL] [Abstract][Full Text] [Related]
9. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
[TBL] [Abstract][Full Text] [Related]
10. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
11. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
12. MDA5 against enteric viruses through induction of interferon-like response partially via the JAK-STAT cascade.
Li Y; Yu P; Qu C; Li P; Li Y; Ma Z; Wang W; de Man RA; Peppelenbosch MP; Pan Q
Antiviral Res; 2020 Apr; 176():104743. PubMed ID: 32057771
[TBL] [Abstract][Full Text] [Related]
13. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus.
Devhare PB; Chatterjee SN; Arankalle VA; Lole KS
PLoS One; 2013; 8(5):e63793. PubMed ID: 23671700
[TBL] [Abstract][Full Text] [Related]
14. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
[TBL] [Abstract][Full Text] [Related]
15. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
16. IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons.
Dang W; Xu L; Yin Y; Chen S; Wang W; Hakim MS; Chang KO; Peppelenbosch MP; Pan Q
Antiviral Res; 2018 Jul; 155():48-59. PubMed ID: 29753657
[TBL] [Abstract][Full Text] [Related]
17. Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression.
Ashley CL; Abendroth A; McSharry BP; Slobedman B
Viruses; 2019 Mar; 11(3):. PubMed ID: 30871003
[TBL] [Abstract][Full Text] [Related]
18. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
19. Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.
Fang L; Choudhary S; Tian B; Boldogh I; Yang C; Ivanciuc T; Ma Y; Garofalo RP; Brasier AR
J Virol; 2015 Mar; 89(5):2628-42. PubMed ID: 25520509
[TBL] [Abstract][Full Text] [Related]
20. Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies.
Devhare PB; Desai S; Lole KS
Sci Rep; 2016 May; 6():26827. PubMed ID: 27230536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]